Panacea Biotec completes transfer of pharmaceuticals business to wholly owned subsidiary

06 Feb 2020 Evaluate

Panacea Biotec has completed transfer of its pharmaceuticals business by way of slump sale (as a going concern) to its wholly-owned subsidiary viz. Panacea Biotec Pharma (PBPL), with an objective to streamline operations and create inherent focus among the businesses of the company.

PBPL obtained the drug manufacturing license on February 1, 2020. Pursuant to this and in compliance with the terms and conditions of the BTA, the transfer of the company's pharmaceuticals business to PBPL by way of slump sale as a going concern has become effective from February 1, 2020.

Panacea Biotec is a leading research based Biotechnology Company with established research, manufacturing and marketing capabilities.

Panacea Biotec Share Price

136.50 0.25 (0.18%)
17-May-2024 12:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1529.60
Dr. Reddys Lab 5810.80
Cipla 1404.90
Zydus Lifesciences 1035.60
Lupin 1652.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.